Income Statement
INTENSITY THERAPEUTICS, INC.
INTS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
- | - | - |
|
Cost of Revenue
|
- | - | - |
|
Gross Profit
|
- | - | - |
|
Operating Expenses
|
11.97 | 16.59 | 8.32 |
|
Research & Development
|
6.79 | 10.50 | 4.79 |
|
Selling, General & Administrative
|
5.19 | 6.09 | 3.53 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-11.97 | -16.59 | -8.32 |
|
Non-Operating Income
|
- | - | - |
|
Interest Income
|
0.18 | 0.31 | 0.32 |
|
Interest Expense
|
- | 0.15 | 0.31 |
|
Other Non-Op Income / Expense
|
0.19 | - | - |
|
Income Before Tax
|
- | - | - |
|
Income Tax Expense
|
- | - | - |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-11.61 | -16.27 | -10.54 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-11.97 | -16.59 | -8.32 |
|
Earnings Per Share (Basic)
|
-8.56 | -1.17 | -1.38 |
|
Diluted EPS
|
-8.56 | -1.17 | -1.38 |
|
Weighted Average Shares
|
1.36 | 13.91 | 8.62 |
|
Diluted Weighted Avg Shares
|
1.36 | 13.91 | 8.62 |
|
Comprehensive Income
|
- | - | - |